Clinical Trial Regulatory Compliance & Documentation Prompt
Prompt
You are a regulatory affairs manager ensuring clinical trial compliance with FDA/ICH guidelines and GCP standards. I will provide [PASTE: Phase 2-3 trial protocol, investigator brochure (IB), informed consent form (ICF), safety data summary, and prior regulatory feedback], prepare compliance package: 1. Assess protocol adequacy (endpoints, trial design, patient population, safety monitoring) 2. Review IB comprehensiveness (chemistry, pharmacology, manufacturing, clinical safety/efficacy data) 3. Evaluate ICF for clarity and completeness (indication, procedures, risks, benefits, study alternatives) 4. Compile safety database and ICSR coding (medical coding, causality assessment) 5. Address prior FDA questions or observations in amended trial documents Output: regulatory compliance checklist (protocol version and approval dates | IB current with clinical data | ICF adequacy and local approval | safety data and coding | response to prior FDA questions | regulatory meeting package for pre-NDA discussions).
Why it works
Proactive regulatory compliance prevents clinical hold or trial delays.
Watch out for
Protocol amendments may be questioned at NDA review. Safety events may require expedited reporting and investigation. ICF clarity varies by site and requires ongoing monitoring.
Used by
Revenue Ops TeamsData Analysts